Difference between revisions of "WSI24-187-Case-1"

From MGH Learn Pathology
(Creating page)
 
(Added status template)
 
Line 29: Line 29:
 
|basedOn=WSI24-187-Case-1
 
|basedOn=WSI24-187-Case-1
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=6347a2ad-d7a5-4d88-ba0e-44c03270bdbe
 
|identifier=6347a2ad-d7a5-4d88-ba0e-44c03270bdbe
Line 39: Line 38:
 
|basedOn=WSI24-187-Case-1
 
|basedOn=WSI24-187-Case-1
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=5fec98c0-5bc3-4576-87ef-26ef8ae50f2f
 
|identifier=5fec98c0-5bc3-4576-87ef-26ef8ae50f2f
Line 49: Line 47:
 
|basedOn=WSI24-187-Case-1
 
|basedOn=WSI24-187-Case-1
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=39878a3a-a124-4a59-b21f-757afb9c3f17
 
|identifier=39878a3a-a124-4a59-b21f-757afb9c3f17
Line 59: Line 56:
 
|basedOn=WSI24-187-Case-1
 
|basedOn=WSI24-187-Case-1
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=48c8723c-4f47-4cb3-86ae-df6c3828b88f
 
|identifier=48c8723c-4f47-4cb3-86ae-df6c3828b88f
Line 69: Line 65:
 
|basedOn=WSI24-187-Case-1
 
|basedOn=WSI24-187-Case-1
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=2539e89b-8090-4cdc-b0c6-a040418da27f
 
|identifier=2539e89b-8090-4cdc-b0c6-a040418da27f
Line 79: Line 74:
 
|basedOn=WSI24-187-Case-1
 
|basedOn=WSI24-187-Case-1
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=bede4375-f183-4b66-9548-5e74050fd411
 
|identifier=bede4375-f183-4b66-9548-5e74050fd411
Line 89: Line 83:
 
|basedOn=WSI24-187-Case-1
 
|basedOn=WSI24-187-Case-1
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=c2d8b13d-9063-4abf-bfc6-cec619759d10
 
|identifier=c2d8b13d-9063-4abf-bfc6-cec619759d10
Line 98: Line 91:
 
|reasonCode=H&E
 
|reasonCode=H&E
 
|basedOn=WSI24-187-Case-1
 
|basedOn=WSI24-187-Case-1
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Cep32
 +
|authoredOn=2024-08-25 21:10:06.014043+00:00
 
}}
 
}}

Latest revision as of 14:30, September 3, 2024

WSI24-187-Case-1
N/A
Gastric-type adenocarcinoma in situ with endometrial involvement
September 5, 2024 12:00:00 PM